Last reviewed · How we verify
The Effect of Two Combined Oral Contraceptives Containing Cyproterone Acetate or Drospirenone on Blood Metabolomics in Women With Polycystic Ovary Syndrome
The aim of this study is to determine the effect of the treatment of polycystic ovary syndrome with two different oral contraceptives that contain cyproterone acetate and drospirenone
Details
| Lead sponsor | Inonu University |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 42 |
| Start date | 2021-03-01 |
| Completion | 2023-06 |
Conditions
- Polycystic Ovary Syndrome
Interventions
- Yasmin
- Diane-35
Primary outcomes
- Metabolomics — 3 months
measured by H1 nuclear magnetic resonance spectroscopy
Countries
Turkey (Türkiye)